Ligence

A delightful #ECR2025 reminder that we are waiting for you from 4 PM in room M147 for a refreshing reception. Directions: Building M is the one where most of the exhibition happens (NOT the one where badges were given). If you are in the badge building, when facing the "Art" turn right and take the long tunnel. Room 147

Forget the formalities—let's enjoy a relaxed moment together! Together with 3 other start-ups, we invite #ECR2025 attendees to join us for a glass of beer or wine. European Innovation Council and SMEs Executive Agency (EISMEA) and Federica Zanca – it’s a pleasure working with you! Reach out to Barbora Butkutė or Dovydas Matuliauskas, MD for more details!

The AI Action Summit was an invitation-only gathering of world leaders, top policymakers, and AI pioneers, where discussions weren’t just theoretical—they were shaping the future. With half of Paris on lockdown, the event underscored the global urgency of AI’s impact. 👉 Read on for our CEO’s insights from the summit.

Ligence at #ECR2025 We're excited to be at #ECR2025, where our experts—MD Dovydas Matuliauskas and Health Economist Barbora Butkutė—will be engaging with PACS providers, ultrasound hardware manufacturers, and innovation leaders. If you're in one of these fields, let’s connect! Schedule a meeting to discover how automated echocardiography can give you a competitive edge in cardiology departments. https://lnkd.in/d_p2C-Pu

🔹 Our insightful CEO Arnas Karužas explains why a 20-person startup innovates in ways big corporations can't. 💡  The average AI development cycle is just 4 months—yet in big corporations, decision-making alone can take up to 2 years. 💡 Despite echocardiography arguably being the most important diagnostic test, fewer than 1% of FDA-cleared AI applications work with ultrasound. Why? Because ultrasound is one of the hardest imaging modalities to automate! At Ligence, we embrace the agility of a startup to tackle the toughest challenges in echocardiography—because innovation shouldn't wait. #echocardiography #ai

To our clients: you clearly have excellent taste! We've crushed another competition and won the consumer solution of the year title! A huge thank you to our consumers for trusting us and to the Artificial Intelligence Association of Lithuania for recognizing our hard work (and exceptional charm). You made this win extra special! We’re not stopping here—this is just the warm-up lap. Stay tuned for more brilliance. #AI #WinnersOnly #TooGoodToIgnore #ConsumerSolutionOfTheYear Arnas Karužas Karolis Šablauskas Dovydas Matuliauskas Antanas Kiziela Justinas Balčiūnas

We're sending a smile straight from our hearts. Literally. Happy Three Kings and 2025! #TTE_of_the_month #echocardiography

It hasn’t been an easy year, but through endurance, we’ve continued creating meaningful change. We didn’t ask for easy—we asked to transform healthcare. To our clients, investors, and supporters who believed in us: thank you. You’ve been our strength and inspiration, our “invincible summer.” Wishing you a peaceful Christmas surrounded by loved ones and a prosperous year ahead! Arnas Karužas Karolis Šablauskas Antanas Kiziela Dovydas Matuliauskas Justinas Balčiūnas

𝐇𝐢𝐬𝐭𝐨𝐫𝐢𝐜 𝐌𝐢𝐥𝐞𝐬𝐭𝐨𝐧𝐞 𝐢𝐧 𝐄𝐜𝐡𝐨𝐜𝐚𝐫𝐝𝐢𝐨𝐠𝐫𝐚𝐩𝐡𝐲: Research with real-world clinical data has shown that 𝐀𝐈 𝐨𝐮𝐭𝐩𝐞𝐫𝐟𝐨𝐫𝐦𝐬 𝐡𝐮𝐦𝐚𝐧 𝐞𝐱𝐩𝐞𝐫𝐭𝐬 in echocardiography for the first time in history. A groundbreaking study led by Dr. Kruno Sveric at the University Clinic of Technische Universität Dresden validated a Ligence Heart against human measurements and CT scans, the gold standard for assessing left ventricular mass. The study involved 164 patients with complex valve conditions, and the AI system demonstrated superior accuracy and closer agreement with CT results than experienced cardiologists. This is a win-win for healthcare: doctors gain more time with their patients, while timely and accurate care becomes accessible globally. #Echocardiography #Cardiology #MedicalAI

Planning your first day at #EuroEcho2024? Don't skip Dr. Sveric Kruno excellent presentation on the gold-standard comparison between echocardiography and CT when validating AI.